Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 69 results for "azelastine"

Combination nasal spray well-tolerated among children with all...

Safety and efficacy of azelastine hydrochloride with fluticasone propionate in a single nasal spray was comparable to fluticasone propionate alone, according to data presented at the American College of Allergy, Asthma and Immunology Annual ... Orthopedics Today, 1 month ago
New and Generic Drug Approvals: Azelastine Hydrochloride U.S. Food and Drug Administration, 1 month ago
New and Generic Drug Approvals: Astelin U.S. Food and Drug Administration, 1 month ago
Financial Express

Deal clincher: Sun hoists its flag on domestic pharma landscape

With the Competition Commission of India (CCI) giving conditional approval to Sun Pharmaceutical Industries proposed acquisition of Ranbaxy Laboratories, the stage is set for Sun Pharma to become the largest pharmaceutical company in India, that too ...
 Financial Express4 days ago

Indian stock markets open firm

Posted by Equitymaster Asian stock markets have opened on a negative note. Barring China (up 0.4%) and Singapore (up 0.2%), all markets opened in red. Japan (down 2.1%) and Korea (down 1.3%) are leading the losses. The Indian stock markets have opened the day ...
 Equitymaster.com1 week ago Indian stock market and companies daily report (December 04, 2014, Thursday)  Stock Markets Review2 weeks ago
Hindu Business Line

Meda, Cipla Suing Apotex

Legal Advice Published on December 8th, 2014 | by Meda Pharmaceuticals Inc. and Cipla Ltd.announced recentlythat they sued Apotex Inc. and Apotex Corp. in U.S. Federal District Court in Delaware to enforce the Orange-Book listed patents ...
 Nordic Life Science1 week ago Meda and Cipla announce suing of Apotex to enforce Dymista patents  Individual.com2 weeks ago Meda And Cipla Ltd. Sue Apotex Corp. To Enforce Dymista┬« Patents  BioSpace2 weeks ago Cipla, Meda sue Apotex in US over nasal spray patent  Hindu Business Line2 weeks ago
[x]  

Court Report - December 2014

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases . Reckitt Benckiser Pharmaceuticals Inc. et al. v. Teva Pharmaceuticals USA Inc. 1:14-cv-01451; filed December 2, 2014 in the District Court of ...
 JD Supra1 week ago
Rediff.com

Sensex snaps 3-day losing streak, jumps 120 points

The benchmark Sensex snapped a three-day losing streak and the Nifty ended firm after hitting a fresh record high led by index heavyweight ITC on reports that the government has deferred its earlier proposal to ban sale of loose cigarettes. The 30-share Sensex ended up 120 points at 28,563 and the 50-share Nifty closed 27 points higher at 8,564 after hitting a record high of 8,626.95. In the broader market, BSE midcap and Smallcap indices ended up 0.3% each. Further, foreign institutional ...
 Rediff.com2 weeks ago Nifty ends firm after record high; ITC up 5%  Business Standard India2 weeks ago Sensex snaps three-day losing streak; ITC up 5%  Business Standard India2 weeks ago

Nifty consolidates around 8,550; Bharti Airtel dips 2%

Markets continued to consolidate in late noon trades on Wednesday as traders turned cautious and booked profits at higher levels. In the broader market, BSE midcap and Smallcap indices outperformed the benchmark indices rising 0.4%-0.5% each. ...
 Business Standard India2 weeks ago

Sensex, Nifty rangebound; Cipla up 2.5%

Benchmark indices are trading flat with a positive bias in the noon trades as gains in FMCG shares cap losses. Further, firm Asian cues have bolstered the sentiments of the market participants. Earlier, the Sensex touched the life-time high level ...
 Business Standard India2 weeks ago Sensex, Nifty range bound; BSE FMCG index gains over 2%  Business Standard India2 weeks ago
Business Standard India

Sensex down over 300 points from day's high; HDFC, Infosys drag

The 30-share Sensex was up 44 points at 28,487 and the 50-share Nifty was flat at 8,437 SI Reporter | Mumbai December 4, 2014 Last Updated at 11:25 IST Benchmark indices which had earlier hit fresh record highs pared most of the gains in late ...
 Business Standard India2 weeks ago

Insurance, defence sector related stocks in demand

Intraday recovery gathered steam, with the 50-unit CNX Nifty hitting fresh intraday high in afternoon trade. The barometer index, the S&P BSE Sensex, was currently up 29.07 points or 0.1% at 28,473.08. The broad market depicted strength. The market ...
 Business Standard India2 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less